Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2025-12-29 @ 5:22 PM
Study NCT ID:
NCT00048568
Status:
COMPLETED
Last Update Posted:
2011-12-05
First Post:
2002-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12
Start Date Type:
None
Primary Completion Date:
2009-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10
Completion Date Type:
ACTUAL
First Submit Date:
2002-11-02
First Submit QC Date:
None
Study First Post Date:
2002-11-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-03-28
Results First Submit QC Date:
None
Results First Post Date:
2011-12-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-10-26
Last Update Post Date:
2011-12-05
Last Update Post Date Type:
ESTIMATED